Search   
Home NYP > Schools > School of Chemical & Life Sciences > Courses > Diploma in Molecular Biotechnology
  

Diploma in Molecular Biotechnology

Course Introduction | Course Structure | Course Module | Career Opportunities | Further Studies | FAQs

 

Course Introduction

The Diploma in Molecular Biotechnology is dedicated to the training of professionals for the Life Sciences industry. If you are envious of biomedical researchers, forensic scientists or inventors of medical kits, this is where you should be. In this course, students are rigorously trained in the basic sciences while being provided with ample opportunities with hands-on training in the latest technology. With the guidance of dedicated lecturers and the support of excellent technical staff, graduates in this course will find themselves trained in the field of Life Sciences for life.

 


 

Course Aims

Students are given a strong foundation in the biomedical sciences, with extensive hands-on laboratory experience and exposure to developments in the industry. We aim to foster an entrepreneurial and innovative mindset in students through the teaching of business skill sets in the context of commercializing research, industrial attachments and projects. As the biomedical sciences are multi-disciplinary, students will also be challenged to think creatively across disciplines.

 

The course equips students with:

  • The knowledge of basic sciences essential to understanding Life Sciences

     

  • A firm grounding in molecular biology, cell biology, microbiology and biochemistry to provide a foundation for specialized topics. The latter include Cell Technology, Applied Microbiology, Immunology, Molecular Genetics, Drug Development, Cell Communication, Histopathology, Haematology and Blood Banking

     

  • Expertise in a wide variety of laboratory techniques, including bio-safety aspects, employed in Biomedical Sciences, Molecular Biology, Biochemistry, Microbiology and Cell Biology

     

  • Specialist skills in the use of IT and databases to address biological questions

     

  • Knowledge of the major technological advances in the biomedical scene, as well as emerging fields of the post genomics era, including proteomics, functional genomics, DNA chips and microarray, stem cells and tissue engineering

     

  • A good understanding of the business concepts and issues relating to intellectual property rights pertinent to the biomedical sciences industry

     

  • Analytical, independent and collaborative learning, research, communication and interpersonal skills

     

  • Awareness of the social and ethical issues that surround the various issues in biomedical sciences

Back to top


 

Career Opportunities

Equipped with industry-relevant skills, graduates will have the opportunity to work in the following challenging and exciting areas:

  • Research and Development (R&D) - Microbiology & Immunology, Molecular Biology & Forensics
    As technologists in R&D and drug development programmes of research institutes and centres.

     

  • Biomedical Sciences
    As technologists in hospital laboratories and clinical centres, as well as clinical trial organisations.

     

  • Bio-Enterprise
    As business development, sales and marketing executives of pharmaceutical, biotechnology and medical devices companies.


 

Further Studies

 

Students who aspire to pursue a degree and meet the entry requirements of the local and overseas universities can progress into the bachelor degree courses in area such as Life Sciences, Biomedical Sciences, Biotechnology, Microbiology, Immunology, Genetics etc.

 

Students who have graduated from this programme have been admitted into various universities. Some of these are:

 

Local 

  • National University of Singapore
  • Nanyang Technological University
  • Duke NUS Medical School

 

Australia 

  • University of Melbourne
  • University of New South Wales
  • University of Queensland
  • University of Newcastle
  • University of Flinders

 

United Kingdom

  • University College London
  • University of Liverpool
  • University of Newcastle
  • University of Manchester

 

United States of America

  • University of Buffalo, New York

 

Back to top

 


  

 FAQs

 

1. What is Molecular Biotechnology?

The term "Biotechnology", first coined in 1919 by a Hungarian engineer (Karl Ereky), is the application of science and engineering in the use of living organisms in their natural or modified forms to produce a product. However, the roots of the technology are as familiar and as ancient as the use of yeast by Egyptians in baking bread - traceable back 6,000 years. With the advent in the early 70's of recombinant DNA technology, biotechnology employed genetic engineering techniques to produce higher quantities and better therapeutics, pharmaceuticals, food and fine chemicals. Biotechnology has also evolved into an interdisciplinary frontier between biology, engineering, medicine, IT and the physical sciences.

 

"Molecular Biotechnology" is the biotechnology of the new millennium. Already the molecular biology tools in biotechnology are providing a major driving force in the Life Sciences industry. With the completion of the Human Genome Project and the subsequent understanding of what our genes do, molecular biotechnology will revolutionizes human healthcare through important biotechnology spin-offs including gene therapy, DNA chip diagnostics, tissue engineering, computer-based rational drug design and nanotechnology.

 

2. Is GCE 'O' level in Biology a prerequisite for Diploma in Molecular Biotechnology?

Click here to find out more.

 

3. What prospects are there for the Diploma in Molecular Biotechnology graduates?

Click here to find out more.

 

4. Comments from leaders in the Life Sciences industry and academia about NYP Diploma in Molecular Biotechnology.

The course is very relevant to the biotech industry and to our activity as we have difficulties in hiring people with such skills…Indeed a lot of candidates have a chemistry or Molecular Biology background, but very few are able to have both of them (or at least an understanding of both of them).
- Genset (Singapore)

 

It has appropriately included new and merging technologies, which are likely to have an impact on the biotechnology and medico-pharmaceutical industries. In particular, I am glad that new techniques in molecular biology are covered, and as a national research laboratory, we are likely to find your graduates highly desirable.
- Defence Medical Research Institute

 

As Singapore needs to ramp up its Life Science manpower rapidly, it will be necessary to have enough numbers of appropriately trained technical staff to help build up the industry. NYP Life science programme is very well thought out and designed to cater for the rapidly evolving Life Science technologies, especially in the area of genomics. The modular nature of the courses allow new tracks to be established easily to respond new developments.
- Singapore Genomics Programme

 

The course is well rounded. It provides adequate basic knowledge in Biology (Molecular and Cellular Systems) and includes modern topics like Genomics, Proteomics and Stem Cells, which are important in Life Science research today and in the future. In addition, the course covers manufacturing concerns in GMP and clinical-related aspects like Biostatistics. The EDB is supportive of this biotechnology course and feel that it will be able to produce diploma graduates who are competent in the basic techniques and issues in modern biotechnology.
- Economic Development Board (EDB)

 

The Diploma has evolved into a very attractive program for both students and the rapidly emerging biopharmaceutical industry. Its focus on the 3 areas of R & D/Drug Development, Bio-Manufacturing and Bio-Enterprise should provide excellent career paths for students as well as identifying specific areas for project collaboration with the pharmaceutical industry in Singapore. I consider that the Diploma as outlined is highly relevant to meeting the training needs of the industry, as well as incorporating the most recent topic areas of the new biotechnology, and I am very happy to give it my strongest possible endorsement
- University of New South Wales

 

Back to top